Natural History and Biological Study of Netherton Syndrome
Not Applicable
Completed
- Conditions
- Netherton SyndromeHealthy
- Registration Number
- NCT02081313
- Lead Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Brief Summary
This study aims at studying the natural history of Netherton syndrome (NS), to identify the consequences of LEKTI deficiency on the immune system and to characterize new molecular mechanisms involved in the disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
- Adult or child (no age limit)
- Confirmed diagnosis of Netherton syndrome
- Signed informed consent form for the patient or his legal representative
Exclusion Criteria
- Bleeding disorder precluding skin biopsy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Measurement of seric cytokines levels 3 months after patient recruitment
- Secondary Outcome Measures
Name Time Method Pattern of skin abnormalities 3 months after patient recruitment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie LEKTI deficiency in Netherton Syndrome pathogenesis?
Are there novel therapeutic targets identified in Netherton Syndrome through immune system analysis?
What biomarkers correlate with disease severity in Netherton Syndrome clinical studies?
How do skin biopsies from Netherton Syndrome patients reveal structural abnormalities in filaggrin processing?
What are the long-term outcomes and quality of life measures in Netherton Syndrome natural history studies?
Trial Locations
- Locations (1)
Imagine Institute for genetic diseases
🇫🇷Paris, France
Imagine Institute for genetic diseases🇫🇷Paris, France